Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis

Supportive Care in Cancer

Volumn 12, Issue 4, 2004, Pages 268-273

  Shaiova, Lauren ^a   Lapin, Jeanne ^a   Manco, Lorraine S ^a   Shasha, Daniel ^a   Hu, Kenneth ^a   Harrison, Louis ^a   Portenoy, Russell K ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Cancer; Mucositis; Oral transmucosal fentanyl citrate; Pain

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; ANTIEMETIC AGENT; ANTIRETROVIRUS AGENT; DIPHENHYDRAMINE; FENTANYL; FENTANYL CITRATE; LAXATIVE; LIDOCAINE; MORPHINE; PLACEBO;

ADULT; ANALGESIA; ARTICLE; BURNING SENSATION; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG FORMULATION; DRUG MEGADOSE; DRUG PREFERENCE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LOZENGE; MALE; MOUTH MUCOSA; MUCOSA INFLAMMATION; PAIN ASSESSMENT; POWDER; PRIORITY JOURNAL; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VISUAL ANALOG SCALE;

ADMINISTRATION, ORAL; ADULT; AGED; ANALGESICS, OPIOID; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FENTANYL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; ORAL ULCER; PAIN MEASUREMENT; PARESTHESIA; PATIENT SATISFACTION; PILOT PROJECTS; PLACEBOS; RADIATION INJURIES; STOMATITIS; TABLETS;

EID: 2442712489     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-004-0595-4     Document Type: Article

References (12)

1. Anderson PM, Ramsay NK, Shu XO, Rydholm N, Rogosheske J, Nicklow R, Weisdorf DJ, Skubitz KM (1998) Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant 22(4):339-344
2. Cancer Therapy Evaluation Program (CTEP) (1999) Common Toxicity Criteria (CTC), Version 2.0. Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, March 1998, p. 12
3. Capelli D, Santini G, De Souza C et al (2000) Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study. Br J Haematol 110(2):300-307
4. Christie JM, Simmonds M, Patt R et al (1998) Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain. J Clin Oncol 16:3238-3245
5. Coda BA, O'Sullivan B, Donaldson G, Bohl S, Chapman CR, Shen DD (1997) Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain 72(3):333-46
6. Collins JJ, Geake J, Grier HE, Houck CS, Thaler HT, Weinstein HJ, Twum-Danso NY, Berde CB. Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone. J Pediatr 1996;129(5):722-728
7. Coluzzi PH, Schwartzberg L, Conroy JD et al (2001) Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain 91:123-130
8. Dunbar PF, Chapman CR, Buckley FP, Gavrin JR (1996) Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCA. Pain 68:265-270
9. Farrar JT, Cleary, J, Rauck R, Busch M, Nordbrock E (1998) Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients. J Natl Cancer Inst 90:611-616
10. Hollander M, Wolfe DA (1999) Non-parametric statistical methods. Wiley, New York p. 46
11. Lichtor JL, Sevarino FB, Joshi GP, Busch MA, Nordbrock E, Ginsberg B (1999) The relative potency of oral transmucosal fentanyl citrate (OTFC) compared with intravenous morphine in the treatment of moderate to severe postoperative pain. Anesth Anal 89(3):732-738
12. Portenoy RK, Payne R, Coluzzi P et al (1999) Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study. Pain 79:303-312